ReviewCNS drugs2001
Glucose for smoking cessation: does it have a role?
Review in CNS drugs, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 40 citations in OpenAlex.
- A randomised trial of glucose tablets to aid smoking cessation.Psychopharmacology · 2010Trial
- Trial
- The Relationship Between Food Craving, Appetite-Related Hormones and Clinical Parameters in Bipolar Disorder.Nutrients · 2020Article
- New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?CNS drugs · 2016Review
- Similarities in food cravings and mood states between obese women and women who smoke tobacco.Obesity (Silver Spring, Md.) · 2009Article
- Effects of cigarette smoking and family history of alcoholism on sweet taste perception and food cravings in women.Alcoholism, clinical and experimental research · 2007Article
- Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotine replacement therapies and amfebutamone (bupropion) have both been shown to aid smoking cessation. However, even with the best support most attempts to stop smoking fail, and many smokers prefer not to use medications in their quit attempts. Oral dextrose (glucose) has been proposed as a possible aid to smoking cessation which would be very inexpensive and might be used by some smokers as well as or instead of medications. It is hypothesised that single doses of nicotine relieve hunger in smokers so that over time smokers therefore come, in certain situations, to interpret sensations associated with hunger as craving for a cigarette. Adaptation to long term nicotine intake leads to exacerbation of these sensations during periods of abstinence. Chewing dextrose tablets results in a rapid increase in blood glucose levels that would be expected to yield a small reduction in these sensations which might then translate into a reduction in craving. An intervention that reduced craving might help smokers to maintain abstinence. Placebo-controlled studies have provided some support for the hypothesis that chewing glucose tablets can reduce desire to smoke during abstinence, and the one adequately powered study carried out so far found that glucose tablets increased 1-month abstinence rates significantly compared with a placebo. Definitive trials are now required but, given their low cost, glucose tablets may be a useful aid for some smokers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.